A new method of measuring tumor progression offers prognostic implications for patients with head and neck squamous cell carcinoma experiencing treatment delays.

News

For patients with oropharyngeal squamous cell carcinoma receiving transoral robotic surgery, adjuvant radiotherapy or chemoradiotherapy should be avoided if possible, according to a long-term functional and quality-of-life outcomes study.

Patients with a non-thyroid cancer who experience hypothyroidism during cancer treatment with a tyrosine kinase inhibitor (TKI) benefit from significantly increased survival compared with those who have normal thyroid function, according to research presented at the 2017 Annual Meeting of the American Thyroid Association (October 18-22, 2017; British Columbia, Canada).

Read More

By Marilynn Larkin

NEW YORK (Reuters Health) – Thyroidectomy rates in Medicare beneficiaries vary 6.2-fold across the United States, suggesting widely divergent local beliefs and practice patterns about how to manage thyroid cancer, researchers say.

Read More

Approximately 66% of patients with medullary thyroid carcinoma do not receive a complete thyroidectomy or central neck lymph-node dissection, despite recommendations in the American Thyroid Guidelines suggesting combining the two procedures.

Read More

Research in Review

A stepped care program has been deemed more cost-effective than care-as-usual in patients with head and neck cancer or lung cancer who have psychological distress, according to a recent study published in the Journal of Clinical Oncology.

-----

Related Content

Read More

Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in The New England Journal of Medicine.

Read More

Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study published in Cancer.

Read More

The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent study. 

Read More

Subscribe to Head & Neck Cancer